Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 30, 2023, titled "Sun Pharma acquires Disperzyme�� and Phlogam�� brands to strengthen its anti-inflammatory portfolio".
Press Release Jan 30 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Jan 25 2023
- Press Release Jan 17 2023
- Press Release Jan 11 2023
- Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures
- Press Release Nov 18 2022
Later from Sun Pharmaceutical Industries
- Press Release Jan 31 2023
- Press Release Feb 10 2023
- Sun Pharmaceutical Industries Limited Press Release Mar 19 2023
- Press Release Mar 22 2023
- Press Release Apr 25 2023
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries